Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Safety Profile of L-Glutamine in Patients with Sickle Cell Disease: Data from Post-Marketing Surveillance

Bhawna Rastogi, Sunita Rani, Meiko Mayuzumi, Rafael Razon, Rajani Singh, Jason Goodrow, Joseph M Becerra, Charles W Stark, Yutaka Niihara

Blood (2021) 138 (Supplement 1): 4184.

https://doi.org/10.1182/blood-2021-154051

Published: 2021

Journal Articles

Consistent Benefit of L-Glutamine Observed across Patients with Low, Medium, and High Number of Crises Reported in the Year Prior to Screening -- Analysis from the Phase 3 Study of L-Glutamine in Sickle Cell Anemia

Yutaka Niihara, MD, Charles William Stark, PharmD, Rafael Razon, MD, Lan T Tran, MPH, Joseph M Becerra, PharmD, Eduard H. Panosyan, MD, Joseph Louis Lasky, MD

Blood (2018) 132 (Supplement 1): 1065.

https://doi.org/10.1182/blood-2018-99-119720

Published: 2018

Journal Articles

Phase 3 Study of L-Glutamine in Sickle Cell Disease: Analyses of Time to First and Second Crisis and Average Cumulative Recurrent Events

Yutaka Niihara, MD, Rafael Razon, MD, Suvankar Majumdar, MD, Brian Claggett, PhD, Onyinye C. Onyekwere, MD, Alan Ikeda, MD, Tammuella Singleton, MD, Andrew Kohei Wood, MS, Rajani Singh, BS, Lan Tran, MPH, Charles William Stark, PharmD

Blood (2017) 130 (Supplement 1): 685.

https://doi.org/10.1182/blood.V130.Suppl_1.685.685

Published: 2017

Journal Articles

Phase 3 Study of L-Glutamine Therapy in Sickle Cell Anemia and Sickle β 0 -Thalassemia Subgroup Analyses Show Consistent Clinical Improvement

Yutaka Niihara, MD, Kusum Viswanathan, MD, Scott T. Miller, MD, Edouard Guillaume, MD, Miren Blackwood, Rafael Razon, MD, Lan Tran, MPH, Charles Stark, Pharm D

Blood (2016) 128 (22): 1318.

https://doi.org/10.1182/blood.V128.22.1318.1318

Published: 2016

Journal Articles

Decrease in the Severity of Painful Sickle Cell Crises with Oral Pglg

Yutaka Niihara, MD, Lan Tran, MPH, Rafael Razon, MD, Charles Stark, Pharm D, Henry Macan, MD

Blood (2015) 126 (23): 2175.

https://doi.org/10.1182/blood.V126.23.2175.2175

Published: 2015

Journal Articles

A Phase 3 Study of L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß 0 -Thalassemia

Yutaka Niihara, MD, Han A. Koh, MD, Lan Tran, MPH, Rafael Razon, MD, Henry Macan, MD, Charles Stark, Pharm.D, Ted Wun, MD, Patricia Adams-Graves, MD

Blood (2014) 124 (21): 86.

https://doi.org/10.1182/blood.V124.21.86.86

Published: 2014

NARROW

Safety Profile of L-Glutamine in Patients with Sickle Cell Disease: Data from Post-Marketing Surveillance

Consistent Benefit of L-Glutamine Observed across Patients with Low, Medium, and High Number of Crises Reported in the Year Prior to Screening -- Analysis from the Phase 3 Study of L-Glutamine in Sickle Cell Anemia

Phase 3 Study of L-Glutamine in Sickle Cell Disease: Analyses of Time to First and Second Crisis and Average Cumulative Recurrent Events

Phase 3 Study of L-Glutamine Therapy in Sickle Cell Anemia and Sickle β 0 -Thalassemia Subgroup Analyses Show Consistent Clinical Improvement

Decrease in the Severity of Painful Sickle Cell Crises with Oral Pglg

A Phase 3 Study of L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß 0 -Thalassemia

Email alerts

ASH Publications

American Society of Hematology

Safety Profile of L-Glutamine in Patients with Sickle Cell Disease: Data from Post-Marketing Surveillance

Consistent Benefit of L-Glutamine Observed across Patients with Low, Medium, and High Number of Crises Reported in the Year Prior to Screening -- Analysis from the Phase 3 Study of L-Glutamine in Sickle Cell Anemia

Phase 3 Study of L-Glutamine in Sickle Cell Disease: Analyses of Time to First and Second Crisis and Average Cumulative Recurrent Events

Phase 3 Study of L-Glutamine Therapy in Sickle Cell Anemia and Sickle β 0 -Thalassemia Subgroup Analyses Show Consistent Clinical Improvement

Decrease in the Severity of Painful Sickle Cell Crises with Oral Pglg

A Phase 3 Study of L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß 0 -Thalassemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only